BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 18270213)

  • 1. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure.
    Borggrefe MM; Lawo T; Butter C; Schmidinger H; Lunati M; Pieske B; Misier AR; Curnis A; Böcker D; Remppis A; Kautzner J; Stühlinger M; Leclerq C; Táborsky M; Frigerio M; Parides M; Burkhoff D; Hindricks G
    Eur Heart J; 2008 Apr; 29(8):1019-28. PubMed ID: 18270213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study.
    Pappone C; Augello G; Rosanio S; Vicedomini G; Santinelli V; Romano M; Agricola E; Maggi F; Buchmayr G; Moretti G; Mika Y; Ben-Haim SA; Wolzt M; Stix G; Schmidinger H
    J Cardiovasc Electrophysiol; 2004 Apr; 15(4):418-27. PubMed ID: 15089990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: A preliminary report.
    Kloppe A; Mijic D; Schiedat F; Bogossian H; Mügge A; Rousso B; Lemke B
    Cardiol J; 2016; 23(1):114-9. PubMed ID: 26503077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration.
    Neelagaru SB; Sanchez JE; Lau SK; Greenberg SM; Raval NY; Worley S; Kalman J; Merliss AD; Krueger S; Wood M; Wish M; Burkhoff D; Nademanee K
    Heart Rhythm; 2006 Oct; 3(10):1140-7. PubMed ID: 17018340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption.
    Butter C; Wellnhofer E; Schlegl M; Winbeck G; Fleck E; Sabbah HN
    J Card Fail; 2007 Mar; 13(2):137-42. PubMed ID: 17395055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure.
    Imai M; Rastogi S; Gupta RC; Mishra S; Sharov VG; Stanley WC; Mika Y; Rousso B; Burkhoff D; Ben-Haim S; Sabbah HN
    J Am Coll Cardiol; 2007 May; 49(21):2120-8. PubMed ID: 17531662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of cardiac contractility modulation in patients with severe congestive heart failure.
    Schau T; Seifert M; Meyhöfer J; Neuss M; Butter C
    Europace; 2011 Oct; 13(10):1436-44. PubMed ID: 21712286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiac contractility modulation: a new option for treating systolic heart failure].
    Rottlaender D; Michels G; Hoppe UC
    Dtsch Med Wochenschr; 2009 Mar; 134(13):639-43. PubMed ID: 19294607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction.
    Müller D; Remppis A; Schauerte P; Schmidt-Schweda S; Burkhoff D; Rousso B; Gutterman D; Senges J; Hindricks G; Kuck KH
    Clin Res Cardiol; 2017 Nov; 106(11):893-904. PubMed ID: 28685207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.
    Abraham WT; Nademanee K; Volosin K; Krueger S; Neelagaru S; Raval N; Obel O; Weiner S; Wish M; Carson P; Ellenbogen K; Bourge R; Parides M; Chiacchierini RP; Goldsmith R; Goldstein S; Mika Y; Burkhoff D; Kadish A;
    J Card Fail; 2011 Sep; 17(9):710-7. PubMed ID: 21872139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac contractility modulation in heart failure patients: Randomized comparison of signal delivery through one vs. two ventricular leads.
    Röger S; Said S; Kloppe A; Lawo T; Emig U; Rousso B; Gutterman D; Borggrefe M; Kuschyk J
    J Cardiol; 2017 Jan; 69(1):326-332. PubMed ID: 27590412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic changes in heart rate on congestive heart failure.
    Rao K; Fisher ML; Robinson S; Shorofsky S; Gottlieb SS
    J Card Fail; 2007 May; 13(4):269-74. PubMed ID: 17517346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of cardiac index and peak exercise oxygen consumption for determining priority for cardiac transplantation.
    Methvin A; Georgiopoulou VV; Kalogeropoulos AP; Malik A; Anarado P; Chowdhury M; Hussain I; Book WM; Laskar SR; Vega JD; Smith AL; Butler J
    Am J Cardiol; 2010 May; 105(9):1353-5. PubMed ID: 20403492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment.
    Inage T; Yoshida T; Hiraki T; Ohe M; Takeuchi T; Nagamoto Y; Fukuda Y; Gondo T; Imaizumi T
    Europace; 2008 Mar; 10(3):379-83. PubMed ID: 18227354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure.
    Feldman AM; Silver MA; Francis GS; Abbottsmith CW; Fleishman BL; Soran O; de Lame PA; Varricchione T;
    J Am Coll Cardiol; 2006 Sep; 48(6):1198-205. PubMed ID: 16979005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac contractility modulation in non-responders to cardiac resynchronization therapy.
    Nägele H; Behrens S; Eisermann C
    Europace; 2008 Dec; 10(12):1375-80. PubMed ID: 18776196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure.
    Stix G; Borggrefe M; Wolpert C; Hindricks G; Kottkamp H; Böcker D; Wichter T; Mika Y; Ben-Haim S; Burkhoff D; Wolzt M; Schmidinger H
    Eur Heart J; 2004 Apr; 25(8):650-5. PubMed ID: 15084369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of baseline electrocardiographic characteristics with the response to cardiac resynchronization therapy for heart failure.
    Reynolds MR; Joventino LP; Josephson ME;
    Pacing Clin Electrophysiol; 2004 Nov; 27(11):1513-8. PubMed ID: 15546306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.